firing up my L2's
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gapper NUVA bounce , chart 1 back
thanks ico, been golfing last 2 days, nice to cover a short for nice profits while on the course!
NUVA taking an ah short 16.90 looking for a flush tomorrow
NUVA big drop ah:
Co anticipates revenue for the third quarter 2012 to be approximately $147 million vs $153.8 mln consensus, which is below the Company's previous comments that suggested flat sequential revenue growth compared to $154.4 million in the second quarter 2012. NuVasive will announce complete revenue and earnings details related to the third quarter 2012 and will update guidance for the full year 2012 when the Company releases earnings on Monday, October 29, 2012, after the close of the market. Co says, "We experienced an unexpected sequential decline in the third quarter due to unusually high account churn related primarily to the growth of surgeon participation in physician-owned distributorships and to increasingly aggressive competitive tactics. As well, we heard from many surgeon customers of increased delays and denials from insurance payers. We believe our ability to take market share with innovative procedural solutions and services remains strong. We are focused on addressing the new challenges and will provide revised full year guidance on our October 29th earnings conference call."
NUVA big drop ah:
Co anticipates revenue for the third quarter 2012 to be approximately $147 million vs $153.8 mln consensus, which is below the Company's previous comments that suggested flat sequential revenue growth compared to $154.4 million in the second quarter 2012. NuVasive will announce complete revenue and earnings details related to the third quarter 2012 and will update guidance for the full year 2012 when the Company releases earnings on Monday, October 29, 2012, after the close of the market. Co says, "We experienced an unexpected sequential decline in the third quarter due to unusually high account churn related primarily to the growth of surgeon participation in physician-owned distributorships and to increasingly aggressive competitive tactics. As well, we heard from many surgeon customers of increased delays and denials from insurance payers. We believe our ability to take market share with innovative procedural solutions and services remains strong. We are focused on addressing the new challenges and will provide revised full year guidance on our October 29th earnings conference call."
Maybe so...and if that is true + Obama hates them, makes them perfects shorts til they add Q's to their tickers
No just the EDU sector brah!
ESI sure does look deathly...probably an accurate adjective if your boy Obama gets another 4! Note to self, short for profits if Otown wins
US Hot stocks
In reiterating its buy rating for online movie-rental company Netflix Inc.
(NFLX, $60.86, +$4.40, +7.79%), Citi noted overall customer satisfaction with
Netflix, according to Citi's survey, has begun to improve for the first time
since last summer, while the company's competitive position as an online-video
destination continues to rise.
Prolor Biotech Inc. (PBTH, $5.21, +$0.15, +2.96%) said it has received a
notice of allowance from the U.S. Patent and Trademark Office for a new patent
application covering the company's long-acting CTP-enhanced human growth
hormone. The patent gives the biopharmaceutical company additional
intellectual-property protection covering methods for the induction of growth
in growth-hormone-deficient patients.
Rigel Pharmaceuticals Inc.'s (RIGL, $9.50, -$0.85, -8.21%) public offering of
13.7 million common shares priced at an 8.2% discount to Tuesday's closing
price, with an offering price of $9.50 a share. The drug developer plans to use
proceeds to fund research and development and for general purposes. The company
had around 71.6 million shares outstanding as of June 30.
Sarepta Therapeutics Inc.'s (SRPT, $41.41, +$26.42, +176.26%) eteplirsen
treatment achieved significant clinical benefit on its primary clinical
outcome--a six-minute walk test--in a longer-term study in Duchenne
muscular-dystrophy patients. The biopharmaceutical company's eteplirsen drug
reached its primary goals after 48 weeks of treatment.
India's Paharpur Cooling Towers Ltd. is in talks to acquire the cooling
business of U.S.-based SPX Corp. (SPW, $67.89, +$3.90, +6.09%) for $500 million
to $600 million, the Economic Times daily reported Wednesday, citing three
people familiar with the situation. SPX spokeswoman Jennifer Epstein didn't
comment on the deal, according to the report.
Oil-field-services company Superior Energy Services Inc. (SPN, $19.12,
-$1.24, -6.09%) said its third-quarter earnings will be lower than it
previously expected, citing Hurricane Isaac's effect on its Gulf of Mexico
operations, among other factors.
US Airways Group Inc.'s (LCC, $11.65, +$0.77, +7.08%) consolidated traffic
rose 2% in September from a year earlier as the airline again reported growth
in its domestic and Latin America segments. The carrier, which also operates US
Airways Shuttle, has been among the most optimistic in the airline industry
about the strength of travel demand.
Shares of small-cap video-ringtone firm Vringo Inc. (VRNG, $4.11, +$1.02,
+33.01%) jumped after a federal judge removed one of the last hurdles that
could have stopped the company from going to trial Oct. 16. Vringo filed a
patent suit against tech heavyweights Google Inc. (GOOG, $762.12, +$5.13,
+0.68%), AOL Inc. (AOL, $36.07, +$0.07, +0.19%) and others. The judge threw out
the defendants' motion for summary judgment--which could have prevented a
trial--and he ordered the parties to "engage in settlement discussions" before
a state magistrate.
Write to Ben Fox Rubin at ben.rubin@dowjones.com.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
October 03, 2012 14:09 ET (18:09 GMT)
Copyright (c) 2012 Dow Jones & Company, Inc.
100312 18:09 -- GMT
Gapper XRTX, figured you had that one as soon as i saw it on the e/r list, takin my chances on a contrarian bet again
Tanker BIOF einhorn denying position
@BobPisani Sell into Bernanke: markets off highs as Fed Chairman defends QE policies
BIOF thanks didn't know Einhorn had BIOF...guess everyone needs a crappy stock to own lol
hahahahaha! how the heck did we stinkin choke?? didn't see it just heard we lost, omgoodness what a choke
EU what a mess. How's that socialism working out?
oh ok wow didn't know that about grafting...
OT: Bagel Foreheads Are the Scariest New Trend in Japan
http://mashable.com/2012/09/27/bagel-heads/
cool thanx
DNDN hard to understand all the nerdy biotech talk, can you cut thru the clutter for us at all?
thank ya!
QE3 puts a floor in on all bad news I guess, but the "buy bad news cuz QE3 is coming" mentality is finished since Ben spoke...prolly will get more of a downward reaction on bad news for several weeks imo, all within modest trading ranges imo
wow....isn't that like several PMI's that show contraction in the last few months?
Stocks to Watch: RIM, Nike, Walgreen
By David B. Wilkerson, MarketWatch
Last Update: 9/27/2012 06:05:12 PM
CHICAGO (MarketWatch) -- Research in Motion Ltd., Nike Inc. and Walgreen Co. are
among the stocks that could see active trading on Friday.
Research In Motion Ltd. shares rose more than 20% in after hours trading Thursday
after the maker of BlackBerry smartphones reported better-than-expected quarterly
results. See full story.
(http://www.marketwatch.com/News/Story/Story.aspx?guid={481989A6-08D7-11E2-95D5-002128049AD6}&siteId=mktw)
Shares of shoe titan Nike Inc. fell more than 2% following the company's report
of a smaller gross margin for its fiscal first quarter. Read about Nike's
results.
(http://www.marketwatch.com/News/Story/Story.aspx?guid={B07B2334-854E-4EF6-9E50-F338831D5B31}&siteId=mktw)
Social-networking company Facebook Inc. unveiled Facebook Gifts, a new feature
that will enable users to give "real gifts" to their Facebook friends. Facebook
shares rose more than 1% late Thursday.
On Friday morning, retail giant Walgreen Co. is seen posting a fiscal
fourth-quarter profit of 56 cents a share on sales of $17.08 billion, according
to analysts surveyed by FactSet.
American Greetings Corp. is expected to report a second-quarter profit of 14
cents a share on sales of $432 million.
Retailer Finish Line Inc. is expected to report a profit of 44 cents a share in
the second quarter, on sales of $358.3 million.
RIMM wow, pain for shorts tomorrow
VIX products: this article has a nice info-graph that lays out everything
http://seekingalpha.com/article/863541-updates-to-the-vix-etp-landscape-add-vixh-drop-12-ubs-etns
Tanker ZZ, history of lackluster Q's
Is it just me or do we seem to have a lot of big up days in the markets on Thursdays lately?
They have a buyout offer on the table...might be maxed out up here but g/l ham
Gapper RIMM earnings contrarian
tiara! wow!
wow nice catch on the steel/coal names thanks for posting
Gapper ROSG momo